Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.

Snell, Cameron E; Gough, Madeline; Middleton, Kathryn; Hsieh, Michael; Furnas, Lauren; Seidl, Brenton; Gibbons, Kristen; Pyke, Christopher; Shannon, Catherine; Woodward, Natasha; Armes, Jane E

Snell, Cameron E; Gough, Madeline; Middleton, Kathryn; Hsieh, Michael; Furnas, Lauren; Seidl, Brenton; Gibbons, Kristen; Pyke, Christopher; Shannon, Catherine; Woodward, Natasha; Armes, Jane E.

Afiliação

Snell CE; Breast Cancer Research Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.
Gough M; The Department of Anatomical Pathology, Mater Pathology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Middleton K; Breast Cancer Research Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.
Hsieh M; The Department of Anatomical Pathology, Mater Pathology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Furnas L; The Department of Medical Oncology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Seidl B; The Department of Anatomical Pathology, Mater Pathology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Gibbons K; The Department of Anatomical Pathology, Mater Pathology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Pyke C; The Department of Medical Oncology, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.
Shannon C; Mater Research Institute-The University of Queensland, South Brisbane, Queensland, Australia.
Woodward N; Mater Research Institute-The University of Queensland, South Brisbane, Queensland, Australia.
Armes JE; The Department of Breast and Endocrine Surgery, Mater Hospital Brisbane, Mater Health Services, South Brisbane, Queensland, Australia.

J Clin Pathol ; 70(11): 954-960, 2017 Nov.

Article em En | MEDLINE | ID: mdl-28416639

Assuntos

Biomarcadores Tumorais/análise; Neoplasias da Mama/tratamento farmacológico; Antagonistas de Estrogênios/uso terapêutico; Linfonodos/química; Recidiva Local de Neoplasia; Receptor ErbB-2/análise; Receptores de Estrogênio/análise; Receptores de Progesterona/análise; Tamoxifeno/uso terapêutico; Adulto; Idoso; Idoso de 80 Anos ou mais; Inibidores da Aromatase/uso terapêutico; Neoplasias da Mama/química; Neoplasias da Mama/patologia; Quimioterapia Adjuvante; Intervalo Livre de Doença; Feminino; Humanos; Imuno-Histoquímica; Estimativa de Kaplan-Meier; Linfonodos/patologia; Metástase Linfática; Pessoa de Meia-Idade; Análise Multivariada; Terapia Neoadjuvante; Valor Preditivo dos Testes; Modelos de Riscos Proporcionais; Queensland; Estudos Retrospectivos; Fatores de Risco; Fatores de Tempo; Análise Serial de Tecidos; Resultado do Tratamento

Palavras-chave

BREAST CANCER; BREAST PATHOLOGY; LYMPH NODES; METASTASIS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Receptores de Progesterona / Receptores de Estrogênio / Biomarcadores Tumorais / Receptor ErbB-2 / Antagonistas de Estrogênios / Linfonodos / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Oceania Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google